Meet the New Biomarkers: Personalizing Cancer Care in 2020

Expert guidance for oncology nurses on key biomarkers in cancer care with a focus on NSCLC and GI malignancies.
Elisabeth King, RN, FNP, AGN, AOCNP
Program Director
person default
Diane Cope, PhD, ARNP-BC, AOCNP
Elisabeth King, RN, FNP, AGN, AOCNP
Sara Toth, RN, MSN, FNP-C, AOCNP, AGN-BC

On-Demand Webcast

Watch this on-demand Webcast of a live CCO Webinar developed for oncology nurses to gain expert perspectives on the role of biomarker testing in the care of patients with cancer, with a focus on new and emerging molecular targets critical to the optimal treatment of lung and gastrointestinal malignancies.

Elisabeth King, RN, FNP, AGN, AOCNP
Program Director
person default Diane Cope, PhD, ARNP-BC, AOCNP Sara Toth, RN, MSN, FNP-C, AOCNP, AGN-BC
Registered Nurses: 1.75 Nursing contact hours Released: July 21, 2020 Expired: July 20, 2021

Downloadable Slidesets

Download these slides with insights for nurses on the role of biomarker testing in the care of patients with cancer.

Elisabeth King, RN, FNP, AGN, AOCNP Released: May 22, 2020

Download these slides with insights for nurses on new and emerging molecular targets critical to the care of patients with lung cancer.

person default Diane Cope, PhD, ARNP-BC, AOCNP Released: May 22, 2020

Download these slides with insights for nurses on new and emerging molecular targets critical to the care of patients with gastrointestinal malignancies.

Sara Toth, RN, MSN, FNP-C, AOCNP, AGN-BC Released: May 22, 2020
Provided by the Annenberg Center for Health Sciences at Eisenhower in partnership with Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
Array BioPharma Inc.
Genentech
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue